Dewi Guellec
Overview
Explore the profile of Dewi Guellec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saraux A, Carvajal Alegria G, Dernis E, Roux C, Richez C, Tison A, et al.
Lancet Rheumatol
. 2025 Jan;
PMID: 39818228
Background: Moderate doses of glucocorticoids result in improvements in nearly all patients with polymyalgia rheumatica, but related adverse events are common in older individuals. We aimed to evaluate whether treatment...
2.
Bettacchioli E, Cornec D, Gardien P, Queneherve L, Guellec D, Tison A, et al.
Rheumatol Ther
. 2025 Jan;
PMID: 39808243
Introduction: Celiac disease (CD) affects the small intestine, leading to a progressive disappearance of intestinal villi, and can be found in association with several other autoimmune and inflammatory conditions. The...
3.
Tison A, Jousse-Joulin S, Consigny M, Moog P, Hofauer B, Hachulla E, et al.
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39700419
Objectives: Salivary gland ultrasound (SGUS) has an interest in primary Sjögren's disease (pSD) for diagnosis, but the evolution of parenchymal lesions over time is unknown. The objective of this study...
4.
Georgel L, Benyoussef A, Berrouiguet S, Guellec D, Carvajal Alegria G, Marhadour T, et al.
RMD Open
. 2024 Oct;
10(4.
PMID: 39357926
Objectives: To develop and validate a web-based ecological momentary assessment (EMA) tool to enhance symptoms monitoring among patients with Sjögren's disease (SjD). Methods: Consecutive adults with SjD were enrolled in...
5.
Quere B, Laurier V, Laurier M, Devauchelle-Pensec V, Guellec D, Saraux A
Clin Exp Rheumatol
. 2024 Jun;
42(11):2312-2313.
PMID: 38910567
No abstract available.
6.
DAgostino J, Souki A, Lohse A, Carvajal Alegria G, Dernis E, Richez C, et al.
RMD Open
. 2024 Mar;
10(1).
PMID: 38490696
Objective: The C reactive protein polymyalgia rheumatica activity score (CRP-PMR-AS) is a composite index that includes CRP levels and was developed specifically for PMR. As treatments such as interleukin-6 antagonists...
7.
Astouati Q, Machet T, Houssais C, Noury J, Allenbach Y, Gallay L, et al.
Rheumatology (Oxford)
. 2024 Mar;
64(3):1431-1436.
PMID: 38430004
Objectives: To describe the characteristics of patients with Sjögren's disease (SjD) and inclusion-body myositis (IBM), and how they compare to SjD patients with other inflammatory myopathies (IM). Methods: Patients were...
8.
Quere B, Saraux A, Carvajal-Alegria G, Guellec D, Mouterde G, Lamotte C, et al.
Rheumatol Ther
. 2024 Feb;
11(2):411-423.
PMID: 38372857
Introduction: Major salivary gland ultrasonography (SGUS) demonstrated its good metric properties as an outcome measure for diagnosing primary Sjögren's disease (SD). The objective was to assess SGUS reliability among sonographers...
9.
Mottier D, Girard P, Couturaud F, Lacut K, Le Moigne E, Paleiron N, et al.
NEJM Evid
. 2024 Feb;
2(8):EVIDoa2200332.
PMID: 38320142
BACKGROUND: Admission to the hospital is a major risk factor for the development of venous thromboembolism (VTE). Whether thromboprophylaxis with low-molecular-weight heparin prevents symptomatic VTE in medically ill, hospitalized older...
10.
Saraux A, Le Henaff C, Dernis E, Carvajal-Alegria G, Tison A, Quere B, et al.
Lancet Rheumatol
. 2024 Jan;
5(12):e728-e735.
PMID: 38251563
Background: Medium-dose glucocorticoids can improve symptoms in nearly all patients with polymyalgia rheumatica. According to its good safety profile, abatacept could be used instead of glucocorticoids in early polymyalgia rheumatica....